- Home
- INCR vs CBAT Comparison
INCR vs CBAT Comparison
Compare INCR & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- CBAT
- Stock Information
- Founded
- INCR 1994
- CBAT 1999
- Country
- INCR Israel
- CBAT China
- Employees
- INCR N/A
- CBAT N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- INCR Health Care
- CBAT Miscellaneous
- Exchange
- INCR Nasdaq
- CBAT Nasdaq
- Market Cap
- INCR 76.7M
- CBAT 71.6M
- IPO Year
- INCR N/A
- CBAT N/A
- Fundamental
- Price
- INCR $1.36
- CBAT $0.76
- Analyst Decision
- INCR
- CBAT
- Analyst Count
- INCR 0
- CBAT 0
- Target Price
- INCR N/A
- CBAT N/A
- AVG Volume (30 Days)
- INCR 13.9K
- CBAT 157.9K
- Earning Date
- INCR 04-08-2025
- CBAT 03-17-2025
- Dividend Yield
- INCR N/A
- CBAT N/A
- EPS Growth
- INCR N/A
- CBAT N/A
- EPS
- INCR N/A
- CBAT 0.13
- Revenue
- INCR $72,420,918.00
- CBAT $176,614,609.00
- Revenue This Year
- INCR N/A
- CBAT $28.79
- Revenue Next Year
- INCR $39.30
- CBAT $36.77
- P/E Ratio
- INCR N/A
- CBAT $6.13
- Revenue Growth
- INCR N/A
- CBAT N/A
- 52 Week Low
- INCR $1.17
- CBAT $0.72
- 52 Week High
- INCR $3.72
- CBAT $2.08
- Technical
- Relative Strength Index (RSI)
- INCR 27.25
- CBAT 33.75
- Support Level
- INCR $1.37
- CBAT $0.77
- Resistance Level
- INCR $1.49
- CBAT $0.90
- Average True Range (ATR)
- INCR 0.06
- CBAT 0.05
- MACD
- INCR -0.01
- CBAT -0.01
- Stochastic Oscillator
- INCR 0.00
- CBAT 24.24
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.